Up 938% in 2020, Is Co-Diagnostics Still a Buy in 2021?

Co-Diagnostics (NASDAQ: CODX) was a penny stock at the beginning of 2020, with its shares trading hands for $0.90 at the beginning of the year. By December this biotech stock was up to $9.30. What caused this fantastic run-up, and is there any more gas in the tank? Motley Fool co

Leave a Reply

Your email address will not be published. Required fields are marked *